FDA Chelation Warnings Reflect Growth In Bogus OTCs, Supplements
This article was originally published in The Tan Sheet
Executive Summary
FDA says its Oct. 14 warnings about unapproved autism treatment claims for chelation products marketed as OTCs or dietary supplements reflect a growing problem of fraud in consumer health care product marketing
You may also be interested in...
Regulatory News In Brief
Peanut recalls spread to nutrition bars; Maxam missing supplement manufacturing specs; Amazing Herbs slip on GMPs; FDA finds hygiene errors in Creation’s Garden; Avon, Bioque cosmetics make drug claims; more Regulatory News In Brief.
Regulatory News In Brief
Peanut recalls spread to nutrition bars; Maxam missing supplement manufacturing specs; Amazing Herbs slip on GMPs; FDA finds hygiene errors in Creation’s Garden; Avon, Bioque cosmetics make drug claims; more Regulatory News In Brief.
In Brief
Consent decree follows claim warning